https://doi.org/10.1016/s1470-2045(17)30715-5
J
Jacquie Chirgwin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
2.1K
Citations
17
h-index
20
i10-index
Jacquie Chirgwin is an academic researcher from Box Hill Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Estrogen and related hormone effects & Advanced Breast Cancer Therapies. The author has an h-index of 17, co-authored 46 publications.
ORCID: 0000-0002-4728-9249Papers by this author
worksExtended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
2017 · The Lancet Oncology · 120 citations
Efficacy of a telephone outcall program to reduce caregiver burden among caregivers of cancer patients [PROTECT]: a randomised controlled trial
2018 · BMC Cancer · 65 citations
https://doi.org/10.1186/s12885-017-3961-6
Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy
2021 · Annals of Oncology · 30 citations
https://doi.org/10.1016/j.annonc.2021.07.017
Systemic treatment of <scp>HER</scp>2‐positive metastatic breast cancer: A systematic review
2014 · Asia-Pacific Journal of Clinical Oncology · 20 citations
https://doi.org/10.1111/ajco.12206
Rational use of trastuzumab in metastatic and locally advanced breast cancer: Implications of recent research
2010 · The Breast · 14 citations
https://doi.org/10.1016/j.breast.2010.11.008
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat